axim dm max
Generic: dextromethorphan hydrobromide, guaifenesin
Labeler: vivunt pharma llcDrug Facts
Product Profile
Brand Name
axim dm max
Generic Name
dextromethorphan hydrobromide, guaifenesin
Labeler
vivunt pharma llc
Dosage Form
LIQUID
Routes
Active Ingredients
dextromethorphan hydrobromide 20 mg/20mL, guaifenesin 400 mg/20mL
Manufacturer
Identifiers & Regulatory
Product NDC
82706-013
Product ID
82706-013_0e740063-80d6-c48b-e063-6394a90a3b30
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2024-01-05
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82706013
Hyphenated Format
82706-013
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
axim dm max (source: ndc)
Generic Name
dextromethorphan hydrobromide, guaifenesin (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/20mL
- 400 mg/20mL
Packaging
- 177 mL in 1 BOTTLE, PLASTIC (82706-013-01)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0e740063-80d6-c48b-e063-6394a90a3b30", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0850047780195"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1020138"], "spl_set_id": ["0e7424ea-461f-5ead-e063-6294a90a41b6"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["VIVUNT PHARMA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "177 mL in 1 BOTTLE, PLASTIC (82706-013-01)", "package_ndc": "82706-013-01", "marketing_start_date": "20240105"}], "brand_name": "AXIM DM Max", "product_id": "82706-013_0e740063-80d6-c48b-e063-6394a90a3b30", "dosage_form": "LIQUID", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "82706-013", "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin", "labeler_name": "VIVUNT PHARMA LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "AXIM DM Max", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/20mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/20mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240105", "listing_expiration_date": "20261231"}